And Oncology x2 sale by the end of this year and early next and Merck milestone payment (potentially) early next year for BNC375 moving into Phase 2 trial. (another 20 to 30mil)
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025